Cargando…
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
Despite the fact that a range of vaccines against COVID-19 have already been created and are used for mass vaccination, the development of effective, safe, technological, and affordable vaccines continues. We have designed a vaccine that combines the recombinant protein and DNA vaccine approaches in...
Autores principales: | Borgoyakova, Mariya B., Karpenko, Larisa I., Rudometov, Andrey P., Volosnikova, Ekaterina A., Merkuleva, Iuliia A., Starostina, Ekaterina V., Zadorozhny, Alexey M., Isaeva, Anastasiya A., Nesmeyanova, Valentina S., Shanshin, Daniil V., Baranov, Konstantin O., Volkova, Natalya V., Zaitsev, Boris N., Orlova, Lyubov A., Zaykovskaya, Anna V., Pyankov, Oleg V., Danilenko, Elena D., Bazhan, Sergei I., Shcherbakov, Dmitry N., Taranin, Alexander V., Ilyichev, Alexander A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876144/ https://www.ncbi.nlm.nih.gov/pubmed/35216301 http://dx.doi.org/10.3390/ijms23042188 |
Ejemplares similares
-
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023) -
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022) -
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023) -
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022) -
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Borgoyakova, M. B., et al.
Publicado: (2021)